ELRIG is pleased to invite you to the 5th Annual Research & Innovation Meeting and its new location at
Homerton College, in Cambridge, UK on 29th and 30th March, 2017. Building on the success of the
meeting in previous years, this year will be a larger, 2-day event that will provide expanded scientific
tracks, a larger exhibition and greater networking opportunities with the UK’s most innovative life
Cells as Models of Disease & New Therapeutics
• Single cell analysis including transcriptomics, NGS, micro-fluidics
• Physiologically relevant 3D models & scale-up
PLENARY KEYNOTE SPEAKERS
The meeting will bring together world class speakers and leading academic and industry experts
who will discuss the challenges and opportunities for cells as models of disease to improve the
success of drug discovery and to develop new therapeutic agents. Hear up-to-date views on this
exciting and rapidly evolving area, including presentations on the latest advances and technology
Each year, Research & Innovation provides a highly impactful learning and networking opportunity for
scientists engaged in early-phase drug discovery whether in Academia, Biotech or Pharma. Scientific
sessions are complemented by a poster session, networking opportunities and a vendor exhibition
with over 40 exhibitors, including recently formed companies with new and disruptive technologies.
This meeting will facilitate new ideas and potentiate the cellular models field as it expands into new
areas of research and discovery.
Join us for this must-attend event to learn about new state-of-the-art technologies and the latest
research and innovation trends in drug discovery!
VP and General Manager at
Corning Life Sciences
Poster Taster abstract deadline: 17th Feb 2017
General poster abstract deadline: 17th March 2017
CALL FOR POSTERS
Sanj Kumar, ELRIG Sales Director
firstname.lastname@example.org +44 7860 892 944
SPONSORSHIP & EXHIBITION
29th - 30th MARCH 2017, HOMERTON COLLEGE, CAMBRIDGE
Follow us on Twitter @ELRIG_UK for all the latest information on ELRIG events and news.
Investment Committee Chair at